My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
May 2012
Top Stories
Antibiotic Incentives Legislation Nearing Passage

As IDSA News went to press, legislation that includes incentives to spur new antibiotic research and development was nearing passage in Congress. IDSA voiced its support for provisions in the Food and Drug Administration Prescription Drug User Fee Act (PDUFA) reauthorization bill in letters earlier this month to Senate (PDF) and House (PDF) committees. IDSA also offered additional proposals for consideration, including the Society’s proposed Limited Population Antibacterial Drug (LPAD) pathway, which would provide an important new approval option for companies interested in developing drugs for serious resistant infections with few or no existing treatment options.

IDSA continues to work on many fronts to address the anemic antibacterial pipeline. A recently launched IDSA webpage, www.AntibioticsNow.org, centers on patients affected by resistant infections and provides an easy way for concerned physicians to urge Congress to act. Visit IDSA’s “Take Action” webpage to send messages to your representatives in Congress on this issue and urge your colleagues to do the same. Members can also help IDSA identify patients and families who are willing to share their experiences with the media, policymakers, and the public. (Several stories are featured on IDSA’s website. Contact IDSA staff for more information.) 
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
Guidance for Increasing Adult Pneumococcal Vaccination Rates
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Legislation Would Repeal Flawed Physician Payment Formula
Physician Groups: “Meaningful Use” Rule Should Encourage EHR Use
Global ID
Combination HIV Drug Recommended for Approval to Prevent HIV Infection
Global Health Funding Updates from Capitol Hill
Study: HIV Funding Does Not Undermine Response to Other Diseases in Rwanda
Policy and Advocacy
Society Continues to Push for Adult Immunization
IDSA, HIVMA Defend Prevention and Public Health Fund
IDSA Comments on FDA Draft Guidance for Developing cUTI Drugs
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
Meet Your Match With the ID/HIV Career Center
Top Stories
Updated Guideline for Diabetic Foot Infections Now Available
Antibiotic Incentives Legislation Nearing Passage
EIN Update: Cryptococcal Disease and Diagnostic Issues
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.